Abstract:For the past 10 years we have been investigating the differential effects of genetic diversity on AIDS pathogenesis and HIV infection. In particular, we are interested in two highly polymorphic immunogenetic systems, namely human leukocyte antigen (HLA) and killer immunoglobulin-like receptor (KIR). The allelic polymorphism of HLA genes and chromosomal organization of KIR genes were characterized in multiple AIDS cohorts to examine their effects on AIDS progression and HIV-1 infection. HLA zygosity and three HLA-B alleles show a consistent association with AIDS: HLA-B*35Px shows a susceptible effect associated with a more rapid progression to AIDS, whereas HLA-B*27, B*57 and HLA heterozygosity show protective effects associated with a slower disease progression. Most immunogenetic effects are detected at the stage of CD4 T-cell depletion, but the B27 protection is most significant in the later stages of AIDS-defining illness. The same three HLA alleles are also associated with different risks for HIV transmission: hemophiliac patients with B*35Px were more likely to transmit HIV-1 to their female partners whereas patients with B*27 and B*57 were less likely to transmit the virus. The protective HLA alleles also correlate with a lower level of HIV viral loads compared to the susceptible alleles. Therefore, one mechanism to explain the observed HLA associations with AIDS is their influence on viral load control. The newly described KIR system is an important component of the innate immune mechanism. These polymorphic receptors regulate NK killing of abnormal cells through recognition of class I HLA expression. Therefore KIR may be involved in many of the diseases for which an HLA influence has been identified. Genetic epistasis between two functionally-relevant immunogenetic systems was observed: the combination of KIR3DS1 and its putative ligand HLA-Bw480I show a significant protection for AIDS progression, but either alone has no effect. Our results demonstrate that genetic polymorphisms of both acquired and innate immune systems influence AIDS pathogenesis and the disease progression. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

KIR/HLA Compound Genotypes Determine Early Antiviral Response of Natural Killer Cells (35.17)

Distinct Kir/Hla Compound Genotypes Affect the Kinetics of Human Antiviral Natural Killer Cell Responses

HIV-1 Induced Changes in HLA-C∗03 : 04-Presented Peptide Repertoires Lead to Reduced Engagement of Inhibitory Natural Killer Cell Receptors

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci.

KLRD1-expressing natural killer cells predict influenza susceptibility

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

125 Immunogenetic polymorphisms and their effects on AIDS progression:

Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians

KIR/HLA Pleiotropism: Protection Against Both HIV and Opportunistic Infections

Host KIR/HLA-C Genotypes Determine HIV-Mediated Changes of the NK Cell Repertoire and Are Associated With Vpu Sequence Variations Impacting Downmodulation of HLA-C

Subordinate Effect of -21M HLA-B Dimorphism on NK Cell Repertoire Diversity and Function in HIV-1 Infected Individuals of African Origin

The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation

KIR3DS1/HLA-B Bw4-80Ile Genotype is Correlated with the IFN-α Therapy Response in Hepatitis B E Antigen-Positive Chronic Hepatitis B

Epistatic Interaction Between KIR3DS1 and HLA-B Delays the Progression to AIDS

HLA-Bw4 in Association with KIR3DL1 Favors Natural Killer Cell-Mediated Protection Against Severe COVID-19

Investigating the Role of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Genetic Variants in Hepatitis C Virus Infection.

GENETICALLY DETERMINED STRENGTH OF NATURAL KILLER CELLS IS ENHANCED BY ADAPTIVE HLA CLASS I ADMIXTURE IN EAST ASIANS

Natural Killer Cells Offer Differential Protection from Leukemia in Chinese Southern Han

Single Nucleotide Polymorphisms in the Human Leukocyte Antigen Region Are Associated with Hemagglutination Inhibition Antibody Response to Influenza Vaccine